Hiroaki Hara

Reply to Comment the Letter Regarding "Development of an Imaging-Based Method for Analyzing Voided Urine Flow Using Conventional and High-Speed Video Cameras: A Phantom Study".

Journal: Lower urinary tract symptoms

Published: August 04, 2026

Development of an Imaging-Based Method for Analyzing Voided Urine Flow Using Conventional and High-Speed Video Cameras: A Phantom Study.

Journal: Lower urinary tract symptoms

Published: October 01, 2025

Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma.

Journal: Clinical genitourinary cancer

Published: December 28, 2024

Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study.

Journal: Japanese journal of clinical oncology

Published: December 08, 2024

Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data.

Journal: Clinical genitourinary cancer

Published: February 05, 2024

The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.

Journal: World journal of urology

Published: December 15, 2023

Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.

Journal: Urologic oncology

Published: January 27, 2023

Cold stress-induced bladder overactivity in type 2 diabetic mellitus rats is mitigated by the combination of a M3 -muscarinic antagonist and a β3 -adrenergic agonist.

Journal: Lower urinary tract symptoms

Published: September 21, 2022

Giant paratesticular liposarcoma with lung metastases: a case report and review of the literature.

Journal: Journal of medical case reports

Published: June 26, 2019

Reply to Comment the Letter Regarding "Development of an Imaging-Based Method for Analyzing Voided Urine Flow Using Conventional and High-Speed Video Cameras: A Phantom Study".

Reply to Comment the Letter Regarding "Development of an Imaging-Based Method for Analyzing Voided Urine Flow Using Conventional and High-Speed Video Cameras: A Phantom Study".

Development of an Imaging-Based Method for Analyzing Voided Urine Flow Using Conventional and High-Speed Video Cameras: A Phantom Study.

Development of an Imaging-Based Method for Analyzing Voided Urine Flow Using Conventional and High-Speed Video Cameras: A Phantom Study.

Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma.

Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma.

Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study.

Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study.

Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data.

Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data.

The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.

The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.

Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.

Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.

Cold stress-induced bladder overactivity in type 2 diabetic mellitus rats is mitigated by the combination of a M3 -muscarinic antagonist and a β3 -adrenergic agonist.

Cold stress-induced bladder overactivity in type 2 diabetic mellitus rats is mitigated by the combination of a M3 -muscarinic antagonist and a β3 -adrenergic agonist.

Giant paratesticular liposarcoma with lung metastases: a case report and review of the literature.

Giant paratesticular liposarcoma with lung metastases: a case report and review of the literature.

Primary male urethral squamous cell carcinoma presenting with a genital abscess.

Primary male urethral squamous cell carcinoma presenting with a genital abscess.

Bilateral Testicular Tumor after Bilateral Orchiopexy : A Case Report

Bilateral Testicular Tumor after Bilateral Orchiopexy : A Case Report